Related Experiment Videos
Immunomodulation by opioid peptidomimetic compound
P Narayan1, V K Singh, S S Agarwal
1Department of Immunology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India.
Neuroimmunomodulation
|December 26, 2001
Summary
Synthetic compound 3 demonstrates significant immunosuppressive potential by inhibiting mixed lymphocyte reactions and cell proliferation. Its effects are mediated via mu-opioid receptors, offering new avenues for immunomodulatory therapies.
Area of Science:
- Immunology
- Medicinal Chemistry
- Pharmacology
Background:
- Opioid peptides have known immunomodulatory effects.
- Previous studies explored immunomodulation with opioid peptides.
- This research focuses on novel synthetic peptidomimetics.
Purpose of the Study:
- Synthesize and evaluate four novel peptidomimetic compounds.
- Assess the immunomodulatory activity of these compounds in vitro.
- Investigate the mechanism of action for potential immunosuppressive agents.
Main Methods:
- Compounds synthesized via solution phase chemistry.
- Immunomodulatory activity assessed using mixed lymphocyte reaction (MLR).
- Cell proliferation, TNF-alpha, and nitric oxide production were measured.
Main Results:
- Compound 3 exhibited significant immunosuppressive properties.
- Compound 3 inhibited two-way MLR and proliferation of mu-opioid receptor-expressing cells.
- Inhibition was reversed by opioid receptor antagonists, indicating mu-opioid receptor involvement.
Conclusions:
- Compound 3 effectively suppresses immune responses in vitro.
- The mechanism of action involves interaction with mu-opioid receptors.
- These findings suggest potential therapeutic applications for compound 3 in immune modulation.